India to Madagascar: Roxithromycin Export Trade Route

The India to Madagascar Roxithromycin corridor is one of India's established pharmaceutical export routes, with 11 shipments documented worth a combined $144.5K USD. The route is dominated by GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED , which alone accounts for roughly 89% of all export value, reflecting the consolidated nature of India's roxithromycin manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $13.1K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 73% of all shipments, consistent with roxithromycin's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 22.6%, placing it at rank #1 among India's top roxithromycin export destinations globally.

On the import side, key buyers of Indian roxithromycin in Madagascar include OPHAM - ROUTE DIGUE ANDRANOAMBO , OPHAM ROUTE DIGUE ANDRANOAMBO LALANA, OPHAM -ROUTE DIGUE ANDRANOAMBO. OPHAM - ROUTE DIGUE ANDRANOAMBO is the single largest importer with 8 shipments valued at $129.0K USD.

India's roxithromycin exports to Madagascar are driven primarily by a handful of large-scale manufacturers. GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Madagascar benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED , GLOBAL PHARMA HEALTH CARE PRIVATE LIMITED, GLOBAL PHARMA HEALTHCARE PRIVATE LIMITED — together account for 100% of total trade value on this route. The average shipment value of $13.1K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as harmless medicine-rox 150 roxithromycin150 mg tablet unit-1x10's qty-10030. and harmless medicinesrox 150 roxithromycin150 mg tablet unit-11x10's qty-11230 .nos, suggesting that buyers in Madagascar tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, OPHAM - ROUTE DIGUE ANDRANOAMBO is the largest importer with 8 shipments worth $129.0K USD — representing 89% of all roxithromycin imports from India on this route.